Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nyxoah SA - Ordinary Shares (NQ:NYXH)

7.650 -0.350 (-4.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 81,871
Open 8.030
Bid (Size) 7.350 (1)
Ask (Size) 11.40 (25)
Prev. Close 8.000
Today's Range 7.410 - 8.080
52wk Range 6.760 - 13.67
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
-15.4%
-15.4%
1 Month
-22.8%
-22.8%
3 Month
-4.4%
-4.4%
6 Month
-21.1%
-21.1%
1 Year
-43.3%
-43.3%

More News

Read More
FDA Issues Nyxoah an Approvable Letter for its Genio® System
From Nyxoah
Via GlobeNewswire
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Earnings Scheduled For March 13, 2025
Via Benzinga
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
From Nyxoah
Via GlobeNewswire
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
From Nyxoah
Via GlobeNewswire
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
From Nyxoah
Via GlobeNewswire
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah Reports Third Quarter Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Nyxoah Appoints John Landry as Chief Financial Officer
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah Raises $27 Million through its At-the-Market Offering
From Nyxoah
Via GlobeNewswire
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
From Nyxoah
Via GlobeNewswire

Frequently Asked Questions

Is Nyxoah SA - Ordinary Shares publicly traded?
Yes, Nyxoah SA - Ordinary Shares is publicly traded.
What exchange does Nyxoah SA - Ordinary Shares trade on?
Nyxoah SA - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Nyxoah SA - Ordinary Shares?
The ticker symbol for Nyxoah SA - Ordinary Shares is NYXH on the Nasdaq Stock Market
What is the current price of Nyxoah SA - Ordinary Shares?
The current price of Nyxoah SA - Ordinary Shares is 7.650
When was Nyxoah SA - Ordinary Shares last traded?
The last trade of Nyxoah SA - Ordinary Shares was at 03/28/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.